Syros Pharmaceuticals Inc (SYRS) Insider Trading
- $21,897,929.58
- $5,881,796.42
- Dec. 2, 2024
- Richard A Young
| Trader Name | Date | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|---|
| Dec. 2, 2024 | Director | 37,070 | $0.27 | Sell | $10,008.90 | |
| Nov. 25, 2024 | Director | 134,713 | $0.27 | Sell | $36,372.51 | |
| Sept. 12, 2024 | CFO | 45,344 | $1.68 | Buy | $76,177.92 | |
| Sept. 10, 2024 | CFO | 35,363 | $1.55 | Buy | $54,812.65 | |
| Sept. 10, 2024 | CEO | 50,000 | $1.51 | Buy | $75,500.00 | |
| June 28, 2024 | Director | 34,837 | $5.12 | Sell | $178,365.44 | |
| April 2, 2024 | Insider | 150 | $4.98 | Sell | $747.00 | |
| Dec. 21, 2023 | Director | 904,977 | $4.42 | Buy | $3,999,998.34 | |
| Dec. 6, 2023 | Insider | 6,287 | $3.95 | Sell | $24,833.65 | |
| July 31, 2023 | Insider | 7,348 | $3.95 | Sell | $29,024.60 | |
| July 17, 2023 | Insider | 689 | $3.50 | Sell | $2,411.50 | |
| Sept. 29, 2022 | Director | 2,932 | $5.72 | Buy | $16,771.04 | |
| Jan. 5, 2022 | Insider | 2,208 | $3.47 | Sell | $7,661.76 | |
| Feb. 16, 2021 | Director | 3,750 | $12.05 | Sell | $45,187.50 | |
| Feb. 8, 2021 | Director | 3,750 | $13.04 | Sell | $48,900.00 | |
| Oct. 19, 2020 | Director | 5,673 | $8.75 | Sell | $49,638.75 | |
| Oct. 15, 2020 | Director | 317 | $8.75 | Sell | $2,773.75 | |
| Sept. 15, 2020 | Director | 5,990 | $10.39 | Sell | $62,236.10 | |
| Aug. 17, 2020 | Insider | 4,963 | $13.00 | Sell | $64,519.00 | |
| Aug. 17, 2020 | Director | 5,990 | $12.59 | Sell | $75,414.10 | |
| July 15, 2020 | Director | 5,990 | $11.85 | Sell | $70,981.50 | |
| July 7, 2020 | Insider | 1,753 | $11.72 | Sell | $20,545.16 | |
| June 25, 2020 | Director | 54,972 | $11.15 | Sell | $612,937.80 | |
| June 23, 2020 | Director | 50,953 | $11.11 | Sell | $566,087.83 | |
| June 15, 2020 | Director | 5,990 | $8.75 | Sell | $52,412.50 | |
| May 15, 2020 | Director | 5,990 | $9.22 | Sell | $55,227.80 | |
| May 13, 2020 | Director | 10,000 | $8.86 | Buy | $88,600.00 | |
| April 15, 2020 | Director | 23,960 | $8.75 | Sell | $209,650.00 | |
| Nov. 11, 2019 | Insider | 9,879 | $4.99 | Buy | $49,296.21 | |
| Aug. 16, 2019 | Director | 25,000 | $10.00 | Sell | $250,000.00 | |
| July 17, 2019 | Major Shareholder | 63,000 | $7.77 | Sell | $489,510.00 | |
| April 9, 2019 | Director | 533,332 | $7.50 | Buy | $3,999,990.00 | |
| March 14, 2019 | Major Shareholder | 167,503 | $7.83 | Sell | $1,311,548.49 | |
| March 11, 2019 | Major Shareholder | 164,583 | $6.80 | Sell | $1,119,164.40 | |
| Jan. 31, 2018 | Director | 209,424 | $9.55 | Buy | $1,999,999.20 | |
| Dec. 15, 2017 | Insider | 15,000 | $9.08 | Buy | $136,200.00 | |
| Dec. 14, 2017 | Director | 109,774 | $9.03 | Buy | $991,259.22 | |
| Oct. 23, 2017 | Insider | 550 | $16.06 | Sell | $8,833.00 | |
| Aug. 14, 2017 | Director | 3,282 | $22.00 | Sell | $72,204.00 | |
| Aug. 7, 2017 | Insider | 2,500 | $23.59 | Sell | $58,975.00 | |
| July 25, 2017 | Insider | 12,500 | $21.85 | Sell | $273,125.00 | |
| July 25, 2017 | Director | 3,282 | $22.09 | Sell | $72,499.38 | |
| July 6, 2016 | Director | 400,000 | $12.50 | Buy | $5,000,000.00 | |
| July 6, 2016 | Major Shareholder | 432,746 | $12.50 | Buy | $5,409,325.00 |
Insiders are both buying and selling Syros Pharmaceuticals Inc stock.
The insider traders at Syros Pharmaceuticals Inc are: Richard A Young, Srinivas Akkaraju, Eric R Olson, David Roth, Venture Fund Vii L.P. Arch, Jason Haas, Jeremy P Springhorn, Nancy A Simonian, Mark J Alles, Conley Chee, Eric R. Olson, Colleen Elizabeth Desimone, Redmile Group, Llc, Robert Nelsen, and Timothy Tyson
The most active insider trader at Syros Pharmaceuticals Inc is Richard A Young with 14 trades.
Venture Fund Vii L.P. Arch has sold the most Syros Pharmaceuticals Inc stock with a total value of $3,409,732.89.
Srinivas Akkaraju has bought the most Syros Pharmaceuticals Inc stock with a total value of $14,991,245.10.
The most recent insider trade for Syros Pharmaceuticals Inc was on Dec. 2, 2024.
The single biggest insider buy for Syros Pharmaceuticals Inc was from Redmile Group, Llc with a total value of $5,409,325.00 on July 6, 2016.
The single biggest insider sell for Syros Pharmaceuticals Inc was from Venture Fund Vii L.P. Arch with a total value of $1,311,548.49 on March 14, 2019.